-
Unusual chest pain and dyspnea Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-04-23 Coralie Eyraud, Julie Cassibba, Marie Suzanne, Justine Suler, Eve Grangette, Guillaume Mortamet, Harriet Corvol
-
Diagnosis of interstitial lung disease after surgery in an adolescent Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-04-23 Fazılcan Zirek, Merve Nur Tekin, Secahattin Bayav, Anar Gurbanov, Merve Havan, Suat Fitoz, Tanıl Kendirli, Nazan Çobanoğlu
-
Clinical and research innovations in childhood interstitial lung disease (chILD) Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-04-23 Jennifer A. Wambach, Timothy J. Vece
-
Mucoepidermoid bronchial tumor in a child masquerading as tuberculosis Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-04-18 Pierre Goussard, André Gie, Shyam Venkatakrishna, Savvas Andronikou, Lars Ebert, Janette Verster, Pawel T. Schubert, Johan Opperman, Jacques Janson
-
Overweight, understudied: The new need for weight loss modalities in CF patients Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-04-17 Sarah Schumacher, Nichole M. Harklau, Julie K. Osterhaus, Brittany A. Wright
-
Outcomes of surgical treatment of tracheobronchomalacia in children Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-04-17 Lana Mukharesh, Katie A. Krone, Thomas E. Hamilton, Hester F. Shieh, Charles J. Smithers, Zachary A. Winthrop, Eleanor D. Muise, Russell W. Jennings, Somala Mohammed, Farokh R. Demehri, Benjamin Zendejas, Gary A. Visner
BackgroundTracheobronchomalacia (TBM) is characterized by excessive dynamic airway collapse. Severe TBM can be associated with substantial morbidity. Children with secondary TBM associated with esophageal atresia/tracheoesophageal fistula (EA/TEF) and vascular‐related airway compression (VRAC) demonstrate clinical improvement following airway pexy surgery. It is unclear if children with severe primary
-
Cystic fibrosis in Iceland and the high prevalence of the N1303K variant Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-04-17 Helga Elidottir, Selma R. Bjarnadottir, Olafur Baldursson, Brynja Jonsdottir
BackgroundCystic fibrosis (CF) is most common in populations of Northern European ancestry where the F508del variant predominates. In 2020, Iceland became a member of the European Cystic Fibrosis Society Patient Registry, and we launched an epidemiological study of CF in Iceland. The study aimed to determine the prevalence and the genetic variants present in the country. Furthermore, we aimed to describe
-
Tracheostomy and inpatient outcomes among children with congenital central hypoventilation syndrome: A kids' inpatient database study Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-04-17 Po‐Yang Tsou, Ignacio E. Tapia
Study ObjectivesCongenital central hypoventilation syndrome (CCHS) is a rare disease predisposing children to respiratory failure due to abnormal ventilatory drive. Variability in hypoventilation and respiratory support need have been reported. We aim to identify clinical variables associated with incident tracheostomy and common etiologies of hospitalization among children with CCHS.MethodsHospital
-
A breath of fresh air: Does spontaneous breathing and early repair in neonates with very mild congenital diaphragmatic hernia lead to earlier discharge? Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-04-17 Pablo Lohmann, Joseph L. Hagan, Caraciolo J. Fernandes
-
Complex pulmonary venous drainage pattern with obstructive partial anomalous pulmonary venous connection and associated meandering pulmonary vein Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-04-17 Dollphy Garg, Riasudeen Naveedh, Pankaj Aggarwal, Arun Sharma, Manphool Singhal
-
Medication utilization and lung function changes after initiation of treatment with elexacaftor/tezacaftor/ivacaftor Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-04-17 Richard De Vuyst, Charissa W. Kam, Cameron J. McKinzie, Charles R. Esther
-
Fibrin IS present in plastic bronchitis casts and can impact treatment! Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-04-17 Deborah R. Liptzin, Livia A. Veress
-
Post‐tuberculosis respiratory impairment in Gambian children and adolescents: A cross‐sectional analysis Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-04-17 Esin Nkereuwem, Schadrac Agbla, Bintou Njai, Victory Fabian Edem, Muhammed Lamin Jatta, Olumuyiwa Owolabi, Uma Masterton, Fatoumatta Jah, Madikoi Danso, Aunty Nyima Fofana, Wandifa Samateh, Muhammed Lamin Darboe, Sheila Ageiwaa Owusu, Andrew Bush, Beate Kampmann, Toyin Togun
BackgroundAlthough post‐tuberculosis lung disease (PTLD) is a known consequence of pulmonary tuberculosis (pTB), few studies have reported the prevalence and spectrum of PTLD in children and adolescents.MethodsChildren and adolescent (≤19 years) survivors of pTB in the Western Regions of The Gambia underwent a respiratory symptom screening, chest X‐ray (CXR) and spirometry at TB treatment completion
-
SHIFTing goals in cystic fibrosis—managing extrapulmonary disease in the era of CFTR modulator therapy; Proceedings of the International Shaping Initiatives and Future Trends (SHIFT) Symposium Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-04-12 Jonathan E. M. O'Donnell, Lucy A. Hastings, Julie N. Briody, Christine L. Chan, Carla Colombo, Tonia A. Douglas, Steven D. Freedman, Tanja Gonska, Jerry R. Greenfield, Daniel H. Leung, Adeline Y. L. Lim, Antoinette Moran, Bernadette J. Prentice, Melissa S. Putman, Michael Trotter, Elizabeth Tullis, Glen P. Westall, Charles F. Verge, Claire E. Wainwright, Chee Y. Ooi
Cystic fibrosis (CF) is a life-shortening multisystem genetic disease. Although progressive pulmonary disease is the predominant cause of morbidity and mortality, improvements in treatment for CF-related lung disease, with associated increase in longevity, have increased the prevalence of extrapulmonary manifestations1.
-
Left pulmonary artery sling and partial anomalous right pulmonary artery in a child with tetralogy of fallot Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-04-12 Pratyaksha Rana, Saurabh Deshpande, Milin Garachh, Megha M. Sheth, Dinesh Patel, Samir Patel
-
Predicting weight gain in patients with cystic fibrosis on triple combination modulator Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-04-12 Kelly L. Stewart, Rhonda Szczesniak, Theodore G. Liou
BackgroundCystic fibrosis (CF) is caused by CF transmembrane conductance regulator (CFTR) gene mutations producing dysfunctional CFTR proteins leading to progressive clinical disease. Elexacaftor‐tezacaftor‐ivacaftor (ETI) remarkably improves lung disease but is associated with substantial weight gain.Study Design and MethodsWe performed a single‐center longitudinal study predicting 6‐month weight
-
Clinical effectiveness of elexacaftor/tezacaftor/ivacaftor in a man with A559T and 3120+1G>CFTR variants Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-04-12 Emily Mitchell, Dana Albon
CONFLICT OF INTEREST STATEMENT The authors declare no conflict of interest.
-
Weaning strategies for children on home invasive mechanical ventilation Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-04-09 Harutai Kamalaporn, Aroonwan Preutthipan, Allan L. Coates
Children who require home mechanical ventilation (HMV) with an artificial airway or invasive mechanical ventilation (HMV) have a possibility of successful weaning due to the potential of compensatory lung growth. Internationally accepted guidelines on how to wean from HMV in children is not available, we summarize the weaning strategies from the literature reviews combined with our 27‐year experience
-
Analysis of mandibular jaw movements to assess ventilatory support management of children with obstructive sleep apnea syndrome treated with positive airway pressure therapies Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-04-09 Julie Cassibba, Guillaume Aubertin, Jean Benoit Martinot, Nam Le Dong, Eglantine Hullo, Nicole Beydon, Audrey Dupont‐Athénor, Guillaume Mortamet, Jean Louis Pépin
BackgroundThe polysomnography (PSG) is the gold‐standard for obstructive sleep apnea (OSA) syndrome diagnosis and assessment under positive airway pressure (PAP) therapies in children. Recently, an innovative digital medicine solution, including a mandibular jaw movement (MJM) sensor coupled with automated analysis, has been validated as an alternative to PSG for pediatric application.ObjectiveThis
-
When acute SARS‐CoV‐2 infection was a blessing in disguise! Unexpected diagnosis and clinical course of hepatopulmonary syndrome in a teenager Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-04-05 Eric S. Mull, Rachel Ronau, Brent Adler, Stephen Kirkby, Jaimie D. Nathan, Alexander Weymann, Archana Shenoy, Grace R. Paul
-
Computed tomography navigation guided transparenchymal nodule biopsy in pediatric patients with pulmonary lesions Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-04-05 Aoife Corcoran, Laura Finn, Joseph Piccione, Pelton Phinizy
-
Bilateral bronchomediastinal fistulae in a child—A double surprise! Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-04-05 Swati Jayaram, Brooke R. Gustafson, Grace R. Paul
CONFLICT OF INTEREST STATEMENT The authors declare no conflict of interest.
-
“A promising solution to the urgent problem of cicatricial narrowing of the larynx and trachea in a pediatric patient with sling syndrome” Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-04-05 Nurgul Seitova, Zaure Tobylbayeva, Mairash Baimuratova, Gulmira Zhauarova, Ruslan Utebaliyev, Almat Bekpan, Darkhan Autalipov, Talgat Ibrayev
CONFLICT OF INTEREST STATEMENT The authors declare no conflicts of interest.
-
Neurally adjusted ventilatory assist in preterm infants: A systematic review and meta‐analysis Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-04-03 Julie Lefevere, Brenda van Delft, Wim Decaluwe, Frank Derriks, Filip Cools
To compare the effects of neurally adjusted ventilatory assist (NAVA) with other forms of synchronized artificial ventilation in preterm infants. A systematic review of randomized and quasi‐randomized controlled trials with individual group allocation, both parallel‐group trials as well as crossover trials, that included preterm infants born at less than 37 weeks gestational age and compared NAVA with
-
Commentary addressing concerns raised by Dr. Slovarp and her colleagues Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-04-03 Miles Weinberger, Dennis Buettner
The commentary by Dr. Laurie Slovarp and her colleagues1 about our previous publication2 finds fault with our terminology, our clinical diagnosis criteria, and the treatment of habit cough in children. Dr. Slovarp refers to the disorder as “Pediatric Nonspecific Cough.” While we will address the concerns expressed by Dr. Slovarp, our purpose in that commentary was to place the interesting data of Dr
-
Development of a bronchopulmonary dysplasia nutrition focused physical examination tool: A modified Delphi study Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-04-01 Jennifer R. Bathgate, Kimberli Pike, Melanie Newkirk, Diane L. Rigassio Radler, Laura Byham‐Gray, Jane Ziegler
ObjectiveThe objectives of this study were to identify factors impacting nutrition needs in infants and children with bronchopulmonary dysplasia (BPD). A modified Delphi approach to obtain consensus among pediatric registered dietitian nutritionists (RDNs) was used to create a BPD‐specific nutrition focused physical examination (NFPE) tool.Study designRDNs, recruited through pediatric nutrition professional
-
Increasing incidence of severe complicated pneumonia in children caused by Streptococcus pyogenes Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-04-01 Katarzyna Tąpolska‐Jóźwiak, Ewelina Gowin, Anna Pasieka, Agata Wasiak, Paulina Stasik, Agnieszka Łoś, Paulina Sobkowiak, Zdzisława Kycler, Katarzyna Jończyk‐Potoczna, Irena Wojsyk‐Banaszak
-
Longitudinal tracking of intrabreath respiratory impedance in preschool children Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-04-01 Matthew D. Wong, Tamara L. Blake, Syeda F. Zahir, Sadasivam Suresh, Zoltán Hantos, Keith Grimwood, Stephen B. Lambert, Robert S. Ware, Peter D. Sly
BackgroundLongitudinal measurements of intrabreath respiratory impedance (Zrs) in preschool‐aged children may be able to distinguish abnormal lung function trajectories in children with a history of wheezing compared to healthy ones.MethodsChildren from a prospective, longitudinal community‐based cohort performed annual intrabreath oscillometry (IB‐OSC) measurements from age 3‐ to 7‐years. IB‐OSC was
-
International disparities in diagnosis and treatment access for cystic fibrosis Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-04-01 Jonathan Guo, Ibukunoluwa King, Andrew Hill
BackgroundElexacaftor/tezacaftor/ivacaftor (ETI) has revolutionized cystic fibrosis (CF) treatment. However, previous research has demonstrated profound global disparities in diagnosis and treatment access. If unaddressed, these threaten to widen existing health inequities. Therefore, in this analysis we aimed to reappraise gaps and evaluate progress in diagnosis and treatment equity in high‐income
-
The Child Opportunity Index 2.0 and exacerbation‐prone asthma in a cohort of urban children Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-04-01 Emily H. Skeen, Camille M. Moore, Monica J. Federico, Max A. Seibold, Andrew H. Liu, Katharine L. Hamlington
RationaleSocial determinants of health underlie disparities in asthma. However, the effects of individual determinants likely interact, so a summary metric may better capture their impact. The Child Opportunity Index 2.0 (COI) is one such tool, yet its association with exacerbation‐prone (EP) asthma is unknown.ObjectiveTo investigate the association between the COI and EP asthma and clinical measures
-
Practices and perspectives on advanced diagnostic and interventional bronchoscopy among pediatric pulmonologists in the United States Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-04-01 A. Corcoran, D. Shore, R. P. Boesch, M. Chopra, S. Das, D. DiBardino, S. Goldfarb, A. Haas, E. Hysinger, P. Phinizy, A. Vicencio, J. Toth, J. Piccione
IntroductionAdvanced diagnostic bronchoscopy includes endobronchial ultrasound (EBUS) guided transbronchial lung and lymph node biopsies, CT navigation and robotic bronchoscopy. Interventional bronchoscopy refers to procedures performed for therapeutic purposes such as balloon dilation of the airway, tissue debulking, cryotherapy, removal of foreign bodies and insertion of endobronchial valves [1]
-
Prevalence, stability, and clinical significance of an isolated low FEV1 spirometry pattern in children Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-04-01 MacKenzie L. Wyatt, Andrew G. Sokolow, Rebekah F. Brown, Jacob A. Kaslow, James J. Tolle, Daniel J. Weiner, Christian Rosas‐Salazar
ObjectivesIn adults, an isolated low FEV1 pattern (an FEV1 below the lower limit of normal with a preserved FVC and FEV1/FVC) has been associated with the risk of developing airway obstruction. Our objective was to examine the prevalence, stability, and clinical significance of an isolated low FEV1 pattern in the pediatric population.MethodsWe conducted a retrospective study of spirometries from children
-
Abnormal bronchial origin in the right middle and lower lung Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-03-29 Hao‐bo Chen, An Xie
Congenital anatomical abnormalities of the pediatric bronchus is a rare and easily overlooked condition. In this study, we identified an 8‐year‐old patient with congenital anomalies of bronchial origin that caused his clinical manifestations of cough and shortness of breath. This diagnosis needs to be taken into possible consideration when similar clinical manifestations occur in a pediatric patient
-
Cover Image, Volume 59, Number 4, April 2024 Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-03-28 Layla Vamos, Julian Allen
-
-
-
Pediatric pulmonology year in review 2023: Physiology Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-03-28 Heather Boas, Clement L. Ren
Application of the principles of pulmonary physiology and lung development to the care and management of respiratory disease in children is a distinguishing feature of pediatric pulmonology. In 2023, this was evident in numerous publications in Pediatric Pulmonology and other journals. This review will highlight some of the papers in this area.
-
Deterioration of lung diffusion capacity during childhood in sickle cell disease Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-03-28 Plamen Bokov, Asmae Zakaria, Berengere Koehl, Malika Benkerrou, Christophe Delclaux
The American Society of Hematology guidelines, 2019, recommended obtaining pulmonary function tests (PFTs) in patients with sickle cell disease (SCD) with various respiratory symptoms even if they are at their steady state.1 These guidelines acknowledged that the usefulness of routine PFT is unknown because of the lack of research. However, this society further suggested that if the PFTs are obtained
-
Virtual interviews and equity: The pediatric pulmonary fellow perspective Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-03-28 Kristen Richard, Laura Chiel, Traci M. Kazmerski, Samar Atteih, Ben Nelson, Robyn Cohen, Theresa A. Laguna, Rachel D'Anna, Suzanne Dahlberg, Magan Zecena, Alicia Casey
Background and ObjectivesThe SARS‐CoV‐2 pandemic shifted medical training programs to utilize virtual interviews (VIs) starting with the 2020 interview cycle. Fellowship interviews continue in the virtual format. It is unknown how this shift has affected equity for applicants as compared to in‐person interviews. Equity in this study includes consideration of the opportunity for an applicant to accept
-
ATS core curriculum 2023. Pediatric pulmonary medicine: Respiratory disorders in infants Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-03-28 Carmen Leon‐Astudillo, Fei J. Dy, Michael Y. McCown, Iris A. Perez, Divya Chhabra, Manvi Bansal, Melissa A. Maloney, Mariana Bedoya, Dima Ezmigna, Douglas Bush, Caroline U. A. Okorie, Jane E. Gross
The American Thoracic Society Core Curriculum updates clinicians annually in pediatric pulmonary disease. This is a summary of the Pediatric Pulmonary Medicine Core Curriculum presented at the 2023 American Thoracic Society International Conference. The respiratory disorders of infancy discussed in this year's review include: the care of the patient with bronchopulmonary dysplasia in the neonatal intensive
-
Pediatric ARDS after Car‐T therapy Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-03-28 Wang Xinhui, Xiang Long
CONFLICT OF INTEREST STATEMENT The authors declare no conflict of interest.
-
Mask interfaces and devices for home noninvasive ventilation in children Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-03-28 Sonia Khirani, Vivian Ducrot
Home noninvasive ventilation (NIV), including continuous (CPAP) and bilevel (BPAP) positive airway pressure, is increasingly used in children worldwide. In this narrative review, we present a comprehensive summary of the equipment available for home NIV in pediatrics, excluding neonates. NIV may be challenging in young children, as the majority of the equipment has been developed for adults. Regarding
-
Role of upper airway evaluation in the multidisciplinary management of obstructive sleep apnea in children below two years of age Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-03-22 Hanne Blancke, Charlotte Platteau, Emma Slosse, Stijn Verhulst, Sophie Installé, Nathalie Jouret, Kim Van Hoorenbeeck, An Boudewyns
BackgroundDiagnosis and treatment of obstructive sleep apnea (OSA) in infants and young children is challenging because of its clinical heterogeneity and lack of age‐specific guidelines.AimWe report the management and treatment outcome of OSA in children below 2 years of age. Treatment decisions were based upon the pattern of upper airway (UA) obstruction, clinical presentation and OSA severity.MethodsRetrospective
-
Opportunities for trauma‐informed medical care in cystic fibrosis Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-03-22 Addison Cuneo, Tess Smith‐Thomas, Meghan Marsac
People living with cystic fibrosis (PwCF) face a lifetime of potentially traumatic medical experiences. These experiences can range from invasive medical treatments (e.g., venipuncture and nasogastric tube placement) to daily illness-related events (e.g., illness-related bullying). These experiences place PwCF at high risk for a type of posttraumatic stress called medical traumatic stress (MTS).1 With
-
Elevated creatine phosphokinase and rhabdomyolysis associated with elexacaftor/tezacaftor/ivacaftor use in cystic fibrosis Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-03-22 Cameron J. McKinzie, Charissa W. Kam, Morgan C. Jones, Laura B. Gifford, Ceila E. Loughlin, Terry L. Noah, Vivek K. Shenoy, Elisabeth P. Dellon
CONFLICT OF INTEREST STATEMENT The authors declare no conflict of interest.
-
Preoperative vaping screening in pediatric patients Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-03-20 Dima Saad, Zena Ghazala, Apuya Jesus, Meenakshi Atteri, Reddy Arundathi, Erhan Ararat
-
Impact of obstructive sleep apnea on clinical outcomes of hospitalization due to influenza in children: A propensity score‐matched analysis of the US Nationwide Inpatient Sample 2005–2018 Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-03-20 Yao Wang, Feng‐Hsiang Chiu
BackgroundPrevious studies have explored the association between obstructive sleep apnea (OSA) and clinical outcomes of influenza in adults, whereas limited research examined this relationship in pediatric populations. This study aimed to evaluate the clinical impact of OSA on the outcomes of pediatric influenza hospitalizations.MethodsThis was a population‐based, retrospective study. Data of children
-
In utero smoking exposure induces changes to lung clearance index and modifies risk of wheeze in infants Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-03-19 Ediane De Queiroz Andrade, Carla Rebeca Da Silva Sena, Patricia de Gouveia Belinelo, Paul D. Robinson, Anneliese Blaxland, Peter D. Sly, Vanessa E. Murphy, Peter G. Gibson, Adam M. Collison, Joerg Mattes
BackgroundFetal exposure to tobacco smoking throughout pregnancy is associated with wheezing in infancy. We investigated the influence of in utero smoking exposure on lung ventilation homogeneity and the relationship between lung ventilation inhomogeneity at 7 weeks of age and wheezing in the first year of life.MethodsMaternal smoking was defined as self‐reported smoking of tobacco or validated by
-
A rare variant c.1802T>C (p. Ile601Thr) associated with severe phenotype among people with cystic fibrosis from south India, and potential genetic admixture in Réunion, France Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-03-19 Madhan Kumar, Rekha Aaron, Sneha D. Varkki, Sumita Danda, Sarath Ranganathan, Grace R. Paul
CONFLICT OF INTEREST STATEMENT The authors declare no conflicts of interest.
-
Bronchopulmonary dysplasia severity and bone status in preterm infants Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-03-19 Ariel Tarrell, Matthew Grinsell, Kimberlee W. Lewis, Bradley A. Yoder, Sabrina Malone Jenkins
To the editor, Bronchopulmonary dysplasia (BPD) and metabolic bone disease (MBD) are both chronic disease complications of prematurity with significant comorbidity.1, 2 Similar associated risk factors link these diseases, including maternal chronic disease or placental insufficiency, extremes of prematurity, low birth weight, inadequate nutrition, mechanical ventilation, sepsis, and others.2, 3 BPD
-
The current state of pediatric asthma in Australia Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-03-19 Shivanthan Shanthikumar, Nusrat Homaira, Brett Montgomery, Harriet Hiscock, Katherine Chen
To the editor, The Australian Institute of Health and Welfare (AIHW) recently released a report regarding Asthma in Australia, including trends over the past 5 years, and pediatric-specific data.1 It used national data sets to assess prevalence, disease burden, and the state of asthma care against a set of predetermined “National Asthma Indicators.” Unfortunately, the report highlights several worrying
-
Tracheal bronchus with segmental bronchial atresia and a supra superior bronchus: An uncommon myriad of airway anomalies Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-03-19 Swaroop G. Hegde, Arnav Shandil, Anmol Bhatia, Kushaljit Singh Sodhi, Jai Kumar Mahajan, Akshay K. Saxena
CONFLICT OF INTEREST STATEMENT The authors declare no conflict of interest.
-
Clinical efficacy of montelukast sodium combination therapy for cough variant asthma in children: A meta‐analysis Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-03-19 Shihai Yang, Xia He, Rixia Zhang
This meta‐analysis aims to assess the clinical effectiveness of combination therapy with montelukast sodium for the treatment of cough variant asthma (CVA) in children, intending to provide clinical evidence and data to guide the selection of clinical therapy. A literature review was conducted using numerous databases, including China National Knowledge Infrastructure (CNKI), Wanfang database, Embase
-
Pancreatitis in cystic fibrosis: Presentation, medical and surgical management, and the impact of modulator therapies Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-03-19 Reza V. Milano, Kayla Morneault‐Gill, Hebat Y. Kamal, Jodie A. Barkin, Christina Baldwin Chadwick
Patients with Cystic Fibrosis (CF) are at increased risk of acute (AP) and chronic (CP) pancreatitis, and their complications. The extent of remaining healthy pancreatic parenchyma determines the risk of developing future episodes of pancreatitis, as well as pancreatic exocrine or endocrine insufficiency. Pancreatitis may be the presenting symptom of CF, and genetic testing is especially important
-
Extracorporeal membrane oxygenation support for balloon atrial septostomy in a BMPR2 variant‐associated pulmonary arterial hypertension Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-03-19 Shoji Fukuoka, Noriyuki Kaku, Hazumu Nagata, Yusaku Nagatomo, Kanako Higashi, Daisuke Toyomura, Yuichiro Hirata, Keiichi Hirono, Kenichiro Yamamura, Shouichi Ohga
-
A comparison of aminoglycoside antibiotic serum concentrations collected by peripheral veins and peripherally inserted central catheters in adults with cystic fibrosis Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-03-19 Sabrina J. Sherwood, Casey Tak, Zubin N. Bhakta, Kristyn Packer, Hollyann Jacobs, Theodore G. Liou, David C. Young
BackgroundPeople with cystic fibrosis (PwCF) are frequently hospitalized for treatment of pulmonary exacerbation. The Cystic Fibrosis Foundation Pulmonary Guidelines support the use of intravenous aminoglycosides with therapeutic drug monitoring for the treatment of pulmonary exacerbation due to Pseudomonas aeruginosa. Serum intravenous tobramycin concentrations are commonly collected by peripheral
-
Obstructive sleep apnea and respiratory viruses in children: A secret alliance uncovered Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-03-19 David Gozal
CONFLICT OF INTEREST STATEMENT The author declares no conflict of interest.
-
Lung and diaphragm ultrasound as predictors of successful weaning from nasal continuous positive airway pressure in preterm infants Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-03-19 Basma Ahmed Nour, Ashraf Mohamed Abd El‐Rahman, Suzy Abd Elmabood Abd El Hameed, Nada Mohsen, Adel Mohamed, Mohammed Attia El‐Bayoumi, Hesham Elsayed Abdel‐Hady
ObjectiveAssessment of the utility of lung and diaphragm ultrasound in the prediction of successful weaning from nasal continuous positive airway pressure (NCPAP) in preterm infants.Study DesignThis prospective cohort study was conducted on preterm infants who were considered ready for weaning off NCPAP. Lung and diaphragm ultrasound were performed just before and 3 h after weaning off NCPAP. The primary
-
Examination of changes in the breathing intolerance index to determine the respiratory support needs of very low birth weight infants Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-03-19 Masae Mizogami, Hisaya Hasegawa, Yosuke Yamada, Masanori Wasa, Kenta Ikeda
BackgroundThe breathing intolerance index (BITI) is used to evaluate respiratory muscle tolerance. The higher the ratio of the inspiratory time to the total breathing time and the ratio of the tidal volume to the vital capacity, the more easily the respiratory muscles become fatigued. The BITI is high with chronic respiratory failure, and values of 0.15 or more indicate the need for assisted ventilation
-
Inpatient education reduces length of outpatient oxygen therapy in bronchopulmonary dysplasia: A quality improvement project Pediatr. Pulmonol. (IF 3.1) Pub Date : 2024-03-19 Kathryn E. K. Berlin, Joanne Lagatta, Sara Dawson, Margaret Malnory, William Scott, Alicia Sprecher
BackgroundPatients discharged on home oxygen therapy (HOT) for bronchopulmonary dysplasia (BPD) often receive months of this therapy. A previous trial comparing two methods of HOT weaning showed that increased parent involvement in HOT weaning decreased HOT duration. Our outpatient team uses a standard protocol for outpatient HOT weaning, starting at the first clinic visit 4–6 weeks after discharge